Emdogain®, a formulation of Enamel Matrix Proteins, is used clinically for periodontal regeneration to stimulate PDL (periodontal ligament), cementum, and bone formation. Its effects on gingival fibroblasts and tissue have not been thoroughly studied. Therefore, we investigated the mechanisms by which Emdogain affects the cell cycle of human gingival fibroblasts. Without serum, Emdogain (50 μg/mL) induced human gingival fibroblast entry into the S phase and DNA synthesis, but not completion of the cell cycle. With low serum concentrations (0.2–0.5%), Emdogain synergistically induced completion of the cell cycle, resulting in increased cell numbers. The mitogenic response to Emdogain depended on Extracellular Regulated Kinase (ERK) activation, which occurred in two waves, peaking after 15 min and 4 to 6 hrs, since it was abolished by U0126, a specific MAPK inhibitor. Inhibition of the second wave was sufficient to abrogate mitogenesis. This study characterized the mitogenic effect of Emdogain on primary human gingival fibroblasts, its cooperation with serum growth factors, and the key mediatory role of the ERK cascade.
Get full access to this article
View all access options for this article.
References
1.
Borenfreund E, Puerner JA -1985-. A simple quantitative procedure using monolayer cultures for cytotoxicity assays -HTD/NR-90-. J Tissue Cult Meth9:7–9.
2.
Buolamwini JK -2000-. Cell cycle molecular targets in novel anticancer drug discovery. Curr Pharm Des6:379–392.
3.
Cattaneo V, Rota C, Silvestri M, Piacentini C, Fornilo A, Gallanti A, et al. -2003-. Effect of enamel matrix derivative on human periodontal fibroblasts: proliferation, morphology and root surface colonization. An in vitro study. J Periodontal Res38:568–574.
4.
Fincham AG, Lau EC, Simmer J, Zeichner-David M -1992-. Amelogenin biochemistry—form and function. In: Chemistry and biology of mineralized tissues. Slavkin HS, Price PE, editors. New York: Elsevier Science Publishers, pp. 187–201.
5.
Gestrelius S, Andersson C, Lidström D, Hammarström L, Somerman M -1997-. In vitro studies on periodontal ligament cells and enamel matrix derivative. J Clin Periodontol24-9 Pt 2-:685–692.
6.
Giannobile WV, Somerman MJ -2003-. Growth and amelogenin-like factors in periodontal wound healing. A systematic review. Ann Periodontol8:193–204.
7.
Granot I, Halevy O, Hurwitz S, Pines M -1993-. Halofuginone: an inhibitor of collagen type I synthesis. Biochim Biophys Acta1156:107–112.
8.
Haase HR, Clarkson RW, Waters MJ, Bartold PM -1998-. Growth factor modulation of mitogenic responses and proteoglycan synthesis by human periodontal fibroblasts. J Cell Physiol174:353–361.
9.
Hagewald S, Spahr A, Rompola E, Haller B, Heijl L, Bernimoulin JP -2002-. Comparative study of Emdogain and coronally advanced flap technique in the treatment of human gingival recessions. A prospective controlled clinical study. J Clin Periodontol29:35–41.
10.
Hagewald S, Pischon N, Jawor P, Bernimoulin JP, Zimmermann B -2004-. Effects of enamel matrix derivative on proliferation and differentiation of primary osteoblasts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod98:243–249.
11.
Hammarström L -1997-. Enamel matrix, cementum development and regeneration. J Clin Periodontol24-9 Pt 2-:658–668.
12.
Huang Z, Cheng SL, Slatopolsky E -2001-. Sustained activation of the extracellular signal-regulated kinase pathway is required for extracellular calcium stimulation of human osteoblast proliferation. J Biol Chem276-Pt 24-:21351–21358.
13.
Kawase K, Okuda H, Yoshie H, Burns DM -2000-. Cytostatic action of enamel matrix derivative -EMDOGAIN®- on human oral squamous cell carcinoma-derived SCC25 epithelial cells. J Periodontal Res35:291–300.
14.
Kawase T, Okuda K, Momose M, Kato Y, Yoshie H, Burns DM -2001-. Enamel matrix derivative -EMDOGAIN®- rapidly stimulates phosphorylation of the MAP kinase family and nuclear accumulation of smad2 in both oral epithelial and fibroblastic human cells. J Periodontal Res36:367–376.
15.
Keila S, Nemcovsky CE, Moses O, Artzi Z, Weinreb M -2004-. In vitro effects of enamel matrix proteins on rat bone marrow cells and gingival fibroblasts. J Dent Res83:134–138.
16.
Koren R, Bercovitz H, Umezawa H, Muller WE -1981-. The role of bestatin, a inhibitor of cell surface proteases, in the interaction of serum with untransformed cells in culture. J Antibiot -Tokyo-34:90–94.
17.
Marcopoulou CE, Vavouraki HN, Dereka XE, Vrotsos IA -2003-. Proliferative effect of growth factors TGF-beta1, PDGF-BB and rhBMP-2 on human gingival fibroblasts and periodontal ligament cells. J Int Acad Periodontol5:63–70.
18.
Matsuda N, Horikawa M, Watanabe M, Kitagawa S, Kudo Y, Takata T -2002-. Possible involvement of extracellular signal-regulated kinases 1/2 in mitogenic response of periodontal ligament cells to enamel matrix derivative. Eur J Oral Sci110:439–444.
19.
Nemcovsky CE, Artzi Z, Tal H, Kozlovsky A, Moses O -2004-. A multicenter comparative study of two root coverage procedures: coronally advanced flap with the addition of enamel matrix proteins and subpedicle connective tissue graft. J Periodontol75:600–607.
20.
Ohyama M, Suzuki N, Yamaguchi Y, Maeno M, Otsuka K, Ito K -2002-. Effect of enamel matrix derivative on the differentiation of C2C12 cells. J Periodontol73:543–550.
21.
Ravid A, Koren R, Rotem C, Garach-Jehoshua O, Glaser T, Liberman UA -1994-. 1,25-Dihydroxyvitamin D3 increases the cellular content of the calcium-activated neutral protease mu-calpain in renal cell carcinoma. Endocrinology135:2822–2825.
22.
Rincon JC, Haase HR, Bartold PM -2003-. Effect of Emdogain® on human periodontal fibroblasts in in vitro wound-healing model. J Periodontal Res38:290–295.
23.
Saati N, Ravid A, Liberman UA, Koren R -1997-. 1,25-dihydroxyvitamin D3 and agents that increase intracellular adenosine 3′,5′-monophosphate synergistically inhibit fibroblast proliferation. In Vitro Cell Dev Biol Anim33:310–314.
24.
Sculean A, Chiantella GC, Windisch P, Donos N -2000-. Clinical and histologic evaluation of human intrabony defects treated with an enamel matrix protein derivative -Emdogain-. Int J Periodontics Restorative Dent20:374–381.
25.
Simmer JP, Fincham AG -1995-. Molecular mechanisms of dental enamel formation. Crit Rev Oral Biol Med6:84–108.
26.
Slavkin HC, Boyd A -1975-. Cementum: a epithelial secretory product? -abstract-. J Dent Res53:157.
27.
Tonetti MS, Fourmousis I, Suva J, Cortellini P, Brägger U, Lang NP, et al. -2004-. Healing, post-operative morbidity and patient perception of outcomes following regenerative therapy of deep intrabony defects. J Clin Periodontol31:1092–1098.
28.
Van der Pauw MT, Van den Bos T, Everts V, Beertsen W -2000-. Enamel matrix-derived protein stimulates attachment of periodontal ligament fibroblasts and enhances alkaline phosphatase activity and transforming growth factor-beta1 release of periodontal ligament and gingival fibroblasts. J Periodontol71:31–43.
29.
Vindelov LL, Christensen IJ, Nissen NI -1983-. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry3:323–327.
